BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34662687)

  • 1. Recent advances in riboflavin transporter RFVT and its genetic disease.
    Jin C; Yonezawa A
    Pharmacol Ther; 2022 May; 233():108023. PubMed ID: 34662687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience.
    Jaeger B; Bosch AM
    J Inherit Metab Dis; 2016 Jul; 39(4):559-64. PubMed ID: 26973221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency.
    O'Callaghan B; Bosch AM; Houlden H
    J Inherit Metab Dis; 2019 Jul; 42(4):598-607. PubMed ID: 30793323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel riboflavin transporter family RFVT/SLC52: identification, nomenclature, functional characterization and genetic diseases of RFVT/SLC52.
    Yonezawa A; Inui K
    Mol Aspects Med; 2013; 34(2-3):693-701. PubMed ID: 23506902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico investigation on structure-function relationship of members belonging to the human SLC52 transporter family.
    Ben Mariem O; Saporiti S; Guerrini U; Laurenzi T; Palazzolo L; Indiveri C; Barile M; De Fabiani E; Eberini I
    Proteins; 2023 May; 91(5):619-633. PubMed ID: 36511838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.
    Foley AR; Menezes MP; Pandraud A; Gonzalez MA; Al-Odaib A; Abrams AJ; Sugano K; Yonezawa A; Manzur AY; Burns J; Hughes I; McCullagh BG; Jungbluth H; Lim MJ; Lin JP; Megarbane A; Urtizberea JA; Shah AH; Antony J; Webster R; Broomfield A; Ng J; Mathew AA; O'Byrne JJ; Forman E; Scoto M; Prasad M; O'Brien K; Olpin S; Oppenheim M; Hargreaves I; Land JM; Wang MX; Carpenter K; Horvath R; Straub V; Lek M; Gold W; Farrell MO; Brandner S; Phadke R; Matsubara K; McGarvey ML; Scherer SS; Baxter PS; King MD; Clayton P; Rahman S; Reilly MM; Ouvrier RA; Christodoulou J; Züchner S; Muntoni F; Houlden H
    Brain; 2014 Jan; 137(Pt 1):44-56. PubMed ID: 24253200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auditory neuropathy in Brown-Vialetto-Van Laere syndrome due to riboflavin transporter RFVT2 deficiency.
    Menezes MP; O'Brien K; Hill M; Webster R; Antony J; Ouvrier R; Birman C; Gardner-Berry K
    Dev Med Child Neurol; 2016 Aug; 58(8):848-54. PubMed ID: 26918385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic, Radiologic, and Clinical Variability in Brown-Vialetto-van Laere Syndrome.
    Woodcock IR; Menezes MP; Coleman L; Yaplito-Lee J; Peters H; White SM; Stapleton R; Phelan DG; Chong B; Lunke S; Stark Z; Pitt J; Ryan MM; Robertson C; Yiu EM
    Semin Pediatr Neurol; 2018 Jul; 26():2-9. PubMed ID: 29961509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome.
    Haack TB; Makowski C; Yao Y; Graf E; Hempel M; Wieland T; Tauer U; Ahting U; Mayr JA; Freisinger P; Yoshimatsu H; Inui K; Strom TM; Meitinger T; Yonezawa A; Prokisch H
    J Inherit Metab Dis; 2012 Nov; 35(6):943-8. PubMed ID: 22864630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC52A2 [p.P141T] and SLC52A3 [p.N21S] causing Brown-Vialetto-Van Laere Syndrome in an Indian patient: First genetically proven case with mutations in two riboflavin transporters.
    Udhayabanu T; Subramanian VS; Teafatiller T; Gowda VK; Raghavan VS; Varalakshmi P; Said HM; Ashokkumar B
    Clin Chim Acta; 2016 Nov; 462():210-214. PubMed ID: 27702554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brown-Vialetto-Van Laere syndrome: A rare case report of MND mimic.
    Kranthi P; Garuda BR; Gopi S; Kumar TS
    Neurol India; 2020; 68(5):1217-1219. PubMed ID: 33109881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete Deletion of Slc52a2 Causes Embryonic Lethality in Mice.
    Jin C; Matsui Y; Yonezawa A; Imai S; Ogihara T; Itohara K; Nakagawa S; Nakagawa T; Matsubara K
    Biol Pharm Bull; 2021; 44(2):283-286. PubMed ID: 33518683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment.
    Bosch AM; Abeling NG; Ijlst L; Knoester H; van der Pol WL; Stroomer AE; Wanders RJ; Visser G; Wijburg FA; Duran M; Waterham HR
    J Inherit Metab Dis; 2011 Feb; 34(1):159-64. PubMed ID: 21110228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brown-Vialetto-Van Laere syndrome: a riboflavin-unresponsive patient with a novel mutation in the C20orf54 gene.
    Koy A; Pillekamp F; Hoehn T; Waterham H; Klee D; Mayatepek E; Assmann B
    Pediatr Neurol; 2012 Jun; 46(6):407-9. PubMed ID: 22633641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brown-Vialetto-van Laere syndrome: a riboflavin responsive neuronopathy of infancy with singular features.
    Spagnoli C; Pitt MC; Rahman S; de Sousa C
    Eur J Paediatr Neurol; 2014 Mar; 18(2):231-4. PubMed ID: 24206674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, pathological and functional characterization of riboflavin-responsive neuropathy.
    Manole A; Jaunmuktane Z; Hargreaves I; Ludtmann MHR; Salpietro V; Bello OD; Pope S; Pandraud A; Horga A; Scalco RS; Li A; Ashokkumar B; Lourenço CM; Heales S; Horvath R; Chinnery PF; Toro C; Singleton AB; Jacques TS; Abramov AY; Muntoni F; Hanna MG; Reilly MM; Revesz T; Kullmann DM; Jepson JEC; Houlden H
    Brain; 2017 Nov; 140(11):2820-2837. PubMed ID: 29053833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riboflavin in Neurological Diseases: A Narrative Review.
    Plantone D; Pardini M; Rinaldi G
    Clin Drug Investig; 2021 Jun; 41(6):513-527. PubMed ID: 33886098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of motor dysfunction in a childhood motor neuron disease caused by mutations in the riboflavin transporter.
    Menezes MP; Farrar MA; Webster R; Antony J; O'Brien K; Ouvrier R; Kiernan MC; Burns J; Vucic S
    Clin Neurophysiol; 2016 Jan; 127(1):911-918. PubMed ID: 26092362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease that is partially rescued by riboflavin.
    Rizzo F; Ramirez A; Compagnucci C; Salani S; Melzi V; Bordoni A; Fortunato F; Niceforo A; Bresolin N; Comi GP; Bertini E; Nizzardo M; Corti S
    Sci Rep; 2017 Apr; 7():46271. PubMed ID: 28382968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Brown-Vialetto-Van Laere Syndrome Due To a Novel Mutation in
    Thulasi V; Veerapandiyan A; Pletcher BA; Tong CM; Ming X
    Child Neurol Open; 2017; 4():2329048X17725610. PubMed ID: 28856173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.